Zobrazeno 1 - 10
of 472
pro vyhledávání: '"RAYMOND L BENZA"'
Autor:
Abhishek Chaturvedi, Manreet Kanwar, Parul Chandrika, Thenappan Thenappan, Amresh Raina, Raymond L Benza
Publikováno v:
Data in Brief, Vol 32, Iss , Pp 106303- (2020)
A comprehensive description of the contemporary trends in pulmonary arterial hypertension (PAH) related hospitalizations, associated inpatient outcomes and predictors of worse outcomes were reported in our paper recently published in the Internationa
Externí odkaz:
https://doaj.org/article/847e6717fb9f43dfaa651cdae312ad7c
Publikováno v:
PLoS ONE, Vol 15, Iss 11, p e0241504 (2020)
BackgroundAccurate and regular risk assessment is important for evaluation and treatment of pulmonary arterial hypertension (PAH) patients, including those with functional class (FC) II symptoms, a population considered at low risk for disease progre
Externí odkaz:
https://doaj.org/article/e284fc12be18401cbbf3b8431ad13a62
Publikováno v:
European Respiratory Review, Vol 33, Iss 171 (2024)
The nitric oxide (NO)–soluble guanylate cyclase (sGC)–cyclic guanosine monophosphate (cGMP) pathway plays a key role in the pathogenesis of pulmonary hypertension (PH). Targeted treatments include phosphodiesterase type 5 inhibitors (PDE5i) and s
Externí odkaz:
https://doaj.org/article/fcc206931a994f66a90b04a503a8a748
Autor:
Raymond L. Benza, Philip B. Adamson, Deepak L. Bhatt, Fredrik Frick, Gunnar Olsson, Niklas Bergh, Björn Dahlöf
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Although rare, pulmonary arterial hypertension (PAH) is associated with substantial morbidity and a median survival of approximately 7 years, even with treatment. Current medical therapies have a primarily vasodilatory effect and do not modi
Externí odkaz:
https://doaj.org/article/ba9468a5ec3649d2ad1715aea913abbe
Autor:
Kellie Morland, Christian Gerges, Jean Elwing, Scott H. Visovatti, Jason Weatherald, Kari R. Gillmeyer, Sandeep Sahay, Stephen C. Mathai, Athénaïs Boucly, Paul G. Williams, Sivadasanpillai Harikrishnan, Evan P. Minty, Lukas Hobohm, Arun Jose, Roberto Badagliacca, Edmund M. T. Lau, Zhi‐Cheng Jing, Rebecca R. Vanderpool, Charles Fauvel, Jose Leonidas Alves Jr., Geoff Strange, Tomas Pulido, Junyan Qian, Mengtao Li, Valentina Mercurio, Jason G. E. Zelt, Victor M. Moles, Meghan M. Cirulis, Sylvia M. Nikkho, Raymond L. Benza, C. Gregory Elliott
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 4, Pp n/a-n/a (2023)
Abstract This manuscript on real‐world evidence (RWE) in pulmonary hypertension (PH) incorporates the broad experience of members of the Pulmonary Vascular Research Institute's Innovative Drug Development Initiative Real‐World Evidence Working Gr
Externí odkaz:
https://doaj.org/article/cbfc593f3e3c499eb6df1025f764229f
Autor:
William H. Marshall V, Stephen Gee, Woobeen Lim, Lauren T. Lastinger, Michael Cackovic, Raymond L. Benza, Curt J. Daniels, Elisa A. Bradley, Saurabh Rajpal
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 8, Iss , Pp 100354- (2022)
Background: Pulmonary hypertension (PH) due to left heart disease (World Health Organization (WHO) Group 2 PH) is the largest PH subgroup, however most reports of PH in pregnancy focus on patients with pulmonary arterial hypertension (WHO Group 1 PH)
Externí odkaz:
https://doaj.org/article/e9a6bf28ea444cafbf38b30179428b43
Autor:
Samuel B. Brusca, Jason M. Elinoff, Yvette Zou, Moon Kyoo Jang, Hyesik Kong, Cumhur Y. Demirkale, Junfeng Sun, Fayaz Seifuddin, Mehdi Pirooznia, Hannah A. Valantine, Carl Tanba, Abhishek Chaturvedi, Grace M. Graninger, Bonnie Harper, Li-Yuan Chen, Justine Cole, Manreet Kanwar, Raymond L. Benza, Ioana R. Preston, Sean Agbor-Enoh, Michael A. Solomon
Publikováno v:
Circulation. 146(14)
Background: Cell-free DNA (cfDNA) is a noninvasive marker of cellular injury. Its significance in pulmonary arterial hypertension (PAH) is unknown. Methods: Plasma cfDNA was measured in 2 PAH cohorts (A, n=48; B, n=161) and controls (n=48). Data were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bddf055d914a456677cd9a6775538e7
https://pubmed.ncbi.nlm.nih.gov/36004627
https://pubmed.ncbi.nlm.nih.gov/36004627
Autor:
Shoaib Fakhri, Kelly Hannon, Kelly Moulden, Ryan Peterson, Peter Hountras, Todd Bull, James Maloney, Teresa De Marco, Dunbar Ivy, Thenappan Thenappan, Jeffrey S. Sager, John J. Ryan, Sula Mazimba, Russel Hirsch, Murali Chakinala, Oksana Shlobin, Matthew Lammi, Dianne Zwicke, Jeffrey Robinson, Raymond L. Benza, James Klinger, Daniel Grinnan, Stephen Mathai, David Badesch
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Background WHO Group 1 pulmonary arterial hypertension is a progressive and potentially fatal disease. Individuals living at higher altitude are exposed to lower barometric pressure and hypobaric hypoxemia. This may result in pulmonary vasoconstricti
Externí odkaz:
https://doaj.org/article/4a56ac6498194904b41f9cd0ff053f23
Autor:
KELLY CHIN, SONIA JAIN, WILLIAM R AUGER, RAYMOND L BENZA, RICHARD N CHANNICK, DUANE DAVIS, CHARLES G ELLIOTT, FENG HE, KIM M KERR, MICHAEL M MADANI, VALLERIE MCLAUGHLIN, MYUNG H PARK, VICTOR F TAPSON, JEFFREY R TERRY, ANDREA LACROIX
Publikováno v:
Chest. 162:A2380-A2383
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d1d6c0fdf1e7726b7d8fc603d1333e3
https://doi.org/10.1016/j.chest.2022.08.1958
https://doi.org/10.1016/j.chest.2022.08.1958
Autor:
KELLY CHIN, SONIA JAIN, WILLIAM R AUGER, RAYMOND L BENZA, RICHARD N CHANNICK, DUANE DAVIS, CHARLES G ELLIOTT, FENG HE, ANDREA LACROIX, MICHAEL M MADANI, VALLERIE MCLAUGHLIN, MYUNG H PARK, VICTOR F TAPSON, JEFFREY R TERRY, KIM M KERR
Publikováno v:
Chest. 162:A2308-A2311
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed6d1caaa9926fb4976fd5a1d868623c
https://doi.org/10.1016/j.chest.2022.08.1914
https://doi.org/10.1016/j.chest.2022.08.1914